Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Marksans Pharma Ltd.

Aug 01 BSE 224.60 ( -3.20 -1.40%)

Volume127789

Prev. Close
227.80

Open Price
225.25

Today's Low / High

220.30 226.80

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

168.05 358.50

Aug 01 NSE 224.86( -2.59 -1.14%)

Volume1264532

Prev. Close
227.45

Open Price
227.28

Today's Low / High

220.23 227.28

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

171.00 358.70

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00
No. of Equity Shares (in Lacs)	4531.64	4531.64	4531.64	4093.14	4093.14

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	45.32	45.32	45.32	40.93	40.93
Total Share Capital	45.32	45.32	45.32	40.93	40.93

Reserves and Surplus	2421.60	2019.74	1699.85	1161.34	845.56
Total Reserves and Surplus	2421.60	2019.74	1699.85	1161.34	845.56
Total Shareholders Funds	2466.91	2065.05	1745.16	1202.27	886.49
Minority Interest	22.47	20.85	19.91	20.70	18.86

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	3.66	10.62	15.39	17.62	8.06
Other Long Term Liabilities	269.25	190.02	65.69	41.43	14.33
Long Term Provisions	0.00	4.56	3.25	1.86	2.11
Total Non-Current Liabilities	272.91	205.20	84.33	60.91	24.50

CURRENT LIABILITIES
Short Term Borrowings	23.09	29.09	41.59	41.29	18.74
Trade Payables	305.70	268.28	230.60	200.08	168.66
Other Current Liabilities	148.56	90.53	67.48	114.12	109.14
Short Term Provisions	0.00	1.96	1.33	0.72	1.85
Total Current Liabilities	477.34	389.85	340.99	356.22	298.40

Total Capital And Liabilities	3239.63	2680.95	2190.39	1640.10	1228.25

ASSETS
NON-CURRENT ASSETS
Tangible Assets	886.41	675.71	379.64	341.59	248.42
Intangible Assets	54.62	60.73	68.17	56.69	60.94
Capital Work-In-Progress	9.00	5.38	7.25	0.70	5.60
Intangible Assets Under Development	18.11	4.04	2.62	1.88	6.08
Fixed Assets	968.14	745.85	457.69	400.86	321.04
Goodwill On Consolidation	40.93	39.50	38.49	30.03	0.00
Deferred Tax Assets [Net]	0.00	0.00	0.00	3.86	0.80
Other Non-Current Assets	26.44	33.11	18.91	4.16	4.16
Total Non-Current Assets	1035.51	818.46	515.09	438.90	326.00


CURRENT ASSETS
Current Investments	0.74	26.99	0.54	0.44	0.00
Inventories	845.52	617.94	484.74	424.44	404.32
Trade Receivables	540.04	453.18	416.85	394.78	271.38
Cash And Cash Equivalents	704.21	673.58	714.96	349.27	212.29
OtherCurrentAssets	113.61	90.80	58.21	32.28	14.26
Total Current Assets	2204.12	1862.49	1675.30	1201.20	902.25

Total Assets	3239.63	2680.95	2190.39	1640.10	1228.25

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	34.15	45.87	9.31	17.02	19.78

CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.74	26.99	0.00	0.00	0.00

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	1.00
No. of Equity Shares (in Lacs)	4531.64

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	45.32
Total Share Capital	45.32
Reserves and Surplus	2421.60
Total Reserves and Surplus	2421.60
Total Shareholders Funds	2466.91
Minority Interest	22.47
NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	3.66
Other Long Term Liabilities	269.25
Long Term Provisions	0.00
Total Non-Current Liabilities	272.91
CURRENT LIABILITIES
Short Term Borrowings	23.09
Trade Payables	305.70
Other Current Liabilities	148.56
Short Term Provisions	0.00
Total Current Liabilities	477.34
Total Capital And Liabilities	3239.63
ASSETS
NON-CURRENT ASSETS
Tangible Assets	886.41
Intangible Assets	54.62
Capital Work-In-Progress	9.00
Intangible Assets Under Development	18.11
Fixed Assets	968.14
Goodwill On Consolidation	40.93
Deferred Tax Assets [Net]	0.00
Other Non-Current Assets	26.44
Total Non-Current Assets	1035.51
CURRENT ASSETS
Current Investments	0.74
Inventories	845.52
Trade Receivables	540.04
Cash And Cash Equivalents	704.21
OtherCurrentAssets	113.61
Total Current Assets	2204.12
Total Assets	3239.63
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	34.15
CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.74